Walleye Trading LLC Exelixis, Inc. Call Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Call Options

25 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$21.96 - $27.6 $4.94 Million - $6.21 Million	-225,000 Reduced 51.72%	210,000 $5.45 Million
Q2 2024 Aug 14, 2024	SELL	$20.34 - $23.73 $433,242 - $505,449	-21,300 Reduced 4.67%	435,000 $9.77 Million
Q1 2024 May 15, 2024	BUY	$20.17 - $23.93 $9.13 Million - $10.8 Million	452,600 Added 12232.43%	456,300 $10.8 Million
Q4 2023 Feb 14, 2024	BUY	$19.25 - $24.13 $44,275 - $55,499	2,300 Added 164.29%	3,700 $88,000
Q3 2023 Nov 14, 2023	SELL	$19.04 - $22.74 $19,040 - $22,740	-1,000 Reduced 41.67%	1,400 $30,000
Q2 2023 Aug 14, 2023	SELL	$18.17 - $20.48 $65,412 - $73,728	-3,600 Reduced 60.0%	2,400 $45,000
Q1 2023 May 15, 2023	BUY	$16.3 - $19.41 $97,800 - $116,460	6,000 New	6,000 $116,000
Q2 2022 Aug 08, 2022	SELL	$17.44 - $23.16 $458,672 - $609,108	-26,300 Reduced 97.41%	700 $15,000
Q1 2022 May 16, 2022	BUY	$17.03 - $22.67 $374,660 - $498,740	22,000 Added 440.0%	27,000 $612,000
Q4 2021 Feb 14, 2022	SELL	$15.84 - $21.88 $1.6 Million - $2.22 Million	-101,300 Reduced 95.3%	5,000 $91,000
Q3 2021 Nov 15, 2021	BUY	$16.3 - $21.14 $1.57 Million - $2.04 Million	96,600 Added 995.88%	106,300 $2.25 Million
Q2 2021 Aug 16, 2021	BUY	$17.95 - $25.56 $165,140 - $235,152	9,200 Added 1840.0%	9,700 $177,000
Q1 2021 May 17, 2021	SELL	$20.53 - $25.22 $100,597 - $123,578	-4,900 Reduced 90.74%	500 $11,000
Q4 2020 Feb 16, 2021	SELL	$18.39 - $24.8 $774,219 - $1.04 Million	-42,100 Reduced 88.63%	5,400 $108,000
Q3 2020 Nov 16, 2020	BUY	$20.67 - $26.94 $981,825 - $1.28 Million	47,500 New	47,500 $1.16 Million
Q2 2020 Aug 14, 2020	SELL	$16.46 - $27.42 $292,988 - $488,076	-17,800 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$14.46 - $21.8 $2.69 Million - $4.06 Million	-186,200 Reduced 91.27%	17,800 $307,000
Q4 2019 Feb 14, 2020	BUY	$15.15 - $18.89 $2.81 Million - $3.5 Million	185,200 Added 985.11%	204,000 $3.59 Million
Q3 2019 Nov 14, 2019	SELL	$17.68 - $22.65 $422,552 - $541,335	-23,900 Reduced 55.97%	18,800 $332,000
Q2 2019 Aug 14, 2019	SELL	$18.93 - $24.75 $581,151 - $759,825	-30,700 Reduced 41.83%	42,700 $912,000
Q1 2019 May 15, 2019	BUY	$19.6 - $24.76 $129,360 - $163,416	6,600 Added 9.88%	73,400 $1.75 Million
Q4 2018 Feb 14, 2019	BUY	$13.65 - $21.8 $803,985 - $1.28 Million	58,900 Added 745.57%	66,800 $1.31 Million
Q3 2018 Nov 14, 2018	SELL	$15.87 - $22.4 $249,159 - $351,680	-15,700 Reduced 66.53%	7,900 $140,000
Q2 2018 Aug 14, 2018	SELL	$18.56 - $22.45 $972,543 - $1.18 Million	-52,400 Reduced 68.95%	23,600 $508,000
Q1 2018 May 15, 2018	BUY	$22.15 - $31.89 $1.68 Million - $2.42 Million	76,000 New	76,000 $1.68 Million

Others Institutions Holding EXEL

# of Institutions

541

Shares Held

245M

Call Options Held

2.84M

Put Options Held

2.29M

Black Rock Inc. New York, NY

33.5M
Shares

$1.12 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.3M
Shares

$981 Million
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

25.4M
Shares

$851 Million
3.31% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.4M
Shares

$514 Million
0.63% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$383 Million
0.01% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.8B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account